Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2020-06-03 Regulatory Filings
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/05/2020. It details movements in authorised and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related movements. It includes confirmations related to securities issued during the month and compliance with listing rules. The document is a regulatory monthly return about share capital movements submitted to the Hong Kong Exchanges and Clearing Limited. It is not a full financial report, earnings release, or management discussion. It is a regulatory filing reporting share capital changes and confirmations, fitting the category of Regulatory Filings (RNS). The document length (14837 characters) and detailed content confirm it is not a brief announcement or a report publication announcement but a substantive regulatory filing.
2020-06-03 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2020-05-28 English
(I) POLL RESULTS OF THE ANNUAL GENERAL MEETING OF 2019 HELD ON MAY 28, 2020 AND (II) 2019 PROFIT DISTRIBUTION PLAN
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results of the Annual General Meeting (AGM) held on May 28, 2020, including resolutions passed and the 2019 profit distribution plan. It details voting outcomes, dividend distribution, and tax information related to dividends. The document is not the full annual report or financial statements themselves but an announcement of the AGM results and dividend plan. It fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) because it reports official shareholder vote results and dividend declarations following the AGM.
2020-05-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2020-05-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2020-05-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/04/2020. It details movements in authorised and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related movements. It includes confirmations related to securities issued, compliance with listing rules, and legal filings. The document is a regulatory monthly return about share capital movements submitted to the Hong Kong Exchanges and Clearing Limited. It is not a full financial report, earnings release, or management discussion. It is a regulatory filing reporting share capital changes and confirmations, fitting the category of Regulatory Filings (RNS). The document length is substantial and contains detailed data, but it is not a report publication announcement or a full financial report. Therefore, the best classification is Regulatory Filings (RNS).
2020-05-06 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.